Trial intelligence / Profile preview

Roxadustat for anemia in liver cirrhosis and effects on HIF-1-alpha

TCTR20230619004Phase 3Completed

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of roxadustat in anaemia, sponsored by Bangabandhu Sheikh Mujib Medical University. Started Dec 2022; status: completed.

02

Drugs

roxadustat
03

Conditions

anaemia

Beyond the preview

Go deeper on TCTR20230619004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230619004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call